The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account Getting audio file ... This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer Inside the Market’s roundup of some of today’s key analyst actions The near-term outlook for Organigram Holdings Inc. (OGI-T) “remains challenged” as revenues “continue to stagnate,” according to Canaccord Genuity analyst Matt Bottomley. After the Moncton-based company reported weaker-than-anticipated first-quarter financial results on Tuesday before the bell, Mr. Bottomley lowered his rating for its shares to “hold” from a “speculative buy” previously.